PACIRA BIOSCIENCES, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $730.4M | $585.6M |
| FY2022 | $689.5M | $775.0M | $104.1M |
| FY2023 | $522.4M | $870.1M | $153.3M |
| FY2024 | $383.5M | $778.3M | $276.8M |
| FY2025 | $372.2M | $693.1M | $158.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $730.4M | $585.6M |
| FY2022 | $689.5M | $775.0M | $104.1M |
| FY2023 | $522.4M | $870.1M | $153.3M |
| FY2024 | $383.5M | $778.3M | $276.8M |
| FY2025 | $372.2M | $693.1M | $158.5M |